Výsledky vyhľadávania - "Diabetic Nephropathies diagnosis"
-
1
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Kidney international, Vol. 106, no.3, p. 369-391 (2024)
Predmety: MESH: Kidney Diseases / diagnosis, MESH: Complement Inactivating Agents / therapeutic use, MESH: Biomarkers / blood, [SDV]Life Sciences [q-bio], Kidney Glomerulus, Komplement-Inhibitor Komplement-vermittelte Verletzung glomeruläre Schädigung, glomerular injury, MESH: Atypical Hemolytic Uremic Syndrome / diagnosis, MESH: Atypical Hemolytic Uremic Syndrome / therapy, MESH: Complement System Proteins / metabolism, Complement Activation, complement inhibitor, MESH: Complement System Proteins / immunology, MESH: Glomerulonephritis / therapy, 16. Peace & justice, Life sciences, 3. Good health, [SDV] Life Sciences [q-bio], Disease Progression, MESH: Disease Progression, Kidney Diseases, ddc:570, complement inhibitor complement-mediated injury glomerular injury, Biologie, MESH: Diabetic Nephropathies / diagnosis, MESH: Glomerulonephritis / immunology, MESH: Complement Activation / immunology, MESH: Diabetic Nephropathies / therapy, Humans, MESH: Kidney Diseases / therapy, MESH: Humans, MESH: Diabetic Nephropathies / etiology, MESH: Glomerulonephritis / diagnosis, Complement System Proteins, Congresses as Topic, MESH: Kidney Glomerulus / pathology, complement-mediated injury, Complement Inactivating Agents, MESH: Kidney Glomerulus / immunology, Biowissenschaften, Biologie, MESH: Atypical Hemolytic Uremic Syndrome / immunology, MESH: Diabetic Nephropathies / immunology, Biowissenschaften, MESH: Kidney Diseases / immunology, MESH: Congresses as Topic, Biomarkers
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38844295
https://inserm.hal.science/inserm-04676176v1
https://inserm.hal.science/inserm-04676176v1/document
https://doi.org/10.1016/j.kint.2024.05.015
https://hdl.handle.net/2078.1/291528
https://hdl.handle.net/11379/607925
https://doi.org/10.1016/j.kint.2024.05.015 -
2
Autori: a ďalší
Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)Predmety: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate
-
3
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Diabetes Metab J
Diabetes & Metabolism Journal, Vol 46, Iss 1, Pp 104-116 (2022)Predmety: Liver Cirrhosis, 0301 basic medicine, liver cirrhosis, Acetylglucosaminidase / urine, Diabetic Nephropathies* / diagnosis, Liver Cirrhosis / diagnosis, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, Acetylglucosaminidase, Diabetes Mellitus, Liver Cirrhosis / complications, acetylglucosaminidase, Humans, Diabetic Nephropathies, Diabetic Nephropathies* / etiology, Type 2* / complications, Type 2* / urine, non-alcoholic fatty liver disease, RC648-665, 3. Good health, type 2, diabetes mellitus, type 2, Diabetes Mellitus, Type 2, Liver cirrhosis, Original Article, Biomarkers, Non-alcoholic fatty liver disease
Prístupová URL adresa: https://www.e-dmj.org/upload/pdf/dmj-2020-0273.pdf
https://pubmed.ncbi.nlm.nih.gov/34253010
https://doaj.org/article/79daad74a8654aae8c3f681ab5840ffd
https://pubmed.ncbi.nlm.nih.gov/34253010/
https://www.e-dmj.org/upload/pdf/dmj-2020-0273.pdf
https://europepmc.org/article/MED/34253010
https://e-dmj.org/journal/view.php?number=2565 -
4
Autori:
Zdroj: Rossing , P , Frimodt-Møller , M & Persson , F 2023 , ' Precision Medicine and/or Biomarker Based Therapy in T2DM : Ready for Prime Time? ' , Seminars in Nephrology , vol. 43 , no. 3 , 151430 . https://doi.org/10.1016/j.semnephrol.2023.151430
Predmety: Humans, Diabetes Mellitus, Type 2/drug therapy, Precision Medicine, Renal Insufficiency, Chronic/diagnosis, Hypertension, Biomarkers, Albuminuria/diagnosis, Glomerular Filtration Rate, Diabetic Nephropathies/diagnosis
Popis súboru: application/pdf
-
5
Autori: a ďalší
Predmety: Adult, Aorta, Abdominal/pathology, Thoracic/pathology, Aortic Diseases/complications, Aortic Diseases/diagnosis, Cohort Studies, Coronary Artery Disease/complications, Coronary Artery Disease/diagnosis, Diabetes Mellitus, Type 1/complications, Type 1/diagnosis, Diabetic Nephropathies/complications, Diabetic Nephropathies/diagnosis, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged
Relation: Circulation; 1524-4539[electronic], 0009-7322[linking]; https://iris.unil.ch/handle/iris/259160; serval:BIB_F214164304EC; 000243523600014
-
6
Autori: a ďalší
Prispievatelia: a ďalší
Zdroj: Clinical Hemorheology and Microcirculation. 72:75-84
Predmety: Male, 0301 basic medicine, Type 2 / complications, Diabetic nephropathy, Diabetic Nephropathies / pathology, 03 medical and health sciences, Hemorheology, 0302 clinical medicine, Erythrocyte Deformability, Diabetes Mellitus, Humans, Type 2 / physiopathology, Diabetic Nephropathies, Erythrocyte Deformability / physiology, hemorheology, elongation index, Diabetic Nephropathies / diagnosis, Middle Aged, RBC deformability, 3. Good health, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/30452406
https://koreauniv.pure.elsevier.com/en/publications/use-of-rbc-deformability-index-as-an-early-marker-of-diabetic -nep
https://pubmed.ncbi.nlm.nih.gov/30452406/
https://ir.ymlib.yonsei.ac.kr/handle/22282913/175818
https://www.ncbi.nlm.nih.gov/pubmed/30452406
https://content.iospress.com/articles/clinical-hemorheology-and-microcirculation/ch180434
https://europepmc.org/article/MED/30452406 -
7
Autori: a ďalší
Zdroj: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-8 (2021)Predmety: Male, Renal Plasma Flow, Insulin Glargine, Linagliptin, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Type 2 diabetes, Renal, Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Insulin Glargine/adverse effects [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Hemodynamics/drug effects [MeSH], Dipeptidyl-Peptidase IV Inhibitors/therapeutic use [MeSH], Metformin/therapeutic use [MeSH], Original Investigation, Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Metformin/adverse effects [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Drug Therapy, Combination [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Diabetic Nephropathies/prevention, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Diabetic Nephropathies/etiology [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Intraglomerular, Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Linagliptin/adverse effects [MeSH], Prospective Studies [MeSH], Renal Plasma Flow/drug effects [MeSH], Insulin Glargine/therapeutic use [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Hemodynamics, Germany [MeSH], Dipeptidyl-Peptidase IV Inhibitors/adverse effects [MeSH], 03 medical and health sciences, 0302 clinical medicine, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, Hypoglycemic Agents, Diabetic Nephropathies, ddc:610, Prospective Studies, Benzhydryl Compounds, Aged, Dipeptidyl-Peptidase IV Inhibitors, Middle Aged, Metformin, 3. Good health, Diabetes Mellitus, Type 2, RC666-701, Drug Therapy, Combination, Female, Glomerular Filtration Rate
Popis súboru: application/pdf
Prístupová URL adresa: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-021-01358-8
https://pubmed.ncbi.nlm.nih.gov/34481498
https://doaj.org/article/9b8533fc41d14d86a46ea53eb65ce82e
https://link.springer.com/article/10.1186/s12933-021-01358-8
https://link.springer.com/content/pdf/10.1186/s12933-021-01358-8.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418746/
https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01358-8
https://opus4.kobv.de/opus4-fau/files/18118/s12933-021-01358-8.pdf
https://repository.publisso.de/resource/frl:6462949 -
8
Prispievatelia: a ďalší
Predmety: COVID-19* / epidemiology, Diabetes Complications* / complications, Diabetes Complications* / epidemiology, Diabetes Mellitus, Type 2* / epidemiology, Diabetic Nephropathies* / diagnosis, Diabetic Nephropathies* / epidemiology, Diabetic Nephropathies* / etiology, Diabetic Retinopathy* / epidemiology, Disease Outbreaks, Humans, Republic of Korea / epidemiology, COVID-19, diabetes, diabetic nephropathy, diabetic retinopathy
Relation: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH; J01111; https://ir.ymlib.yonsei.ac.kr/handle/22282913/188803; T202201628
-
9
Autori: a ďalší
Zdroj: Kidney International. 93:1198-1206
Predmety: Male, 0301 basic medicine, Diabetic nephropathies - diagnosis, Albuminuria - physiopathology, Epidermal growth factor - urine, Blood Pressure, Kidney - physiopathology, Kidney, Biomarkers - blood, Diabetes mellitus, 0302 clinical medicine, Diabetic nephropathies - etiology, Receptors, Hepatitis A virus cellular receptor 1 - blood, Diabetic Nephropathies, Hepatitis A Virus Cellular Receptor 1, Albuminuria - etiology, Middle aged, Diabetic nephropathies - physiopathology, Chemokine CCL2, Risk assessment, Middle Aged, Early diagnosis, Prognosis, type 2 - blood, type 2 - complications, Creatinine, Blood pressure, Disease Progression, Female, Glomerular filtration rate, Glomerular Filtration Rate, Adult, tumor necrosis factor, 03 medical and health sciences, Predictive Value of Tests, Predictive value of tests, Albuminuria, Humans, Creatinine - urine, Disease progression, Epidermal Growth Factor, Time factors, type I - blood, Chemokine CCL2 - urine, Albuminuria - diagnosis, Fibroblast Growth Factor-23, Early Diagnosis, type 2 - diagnosis, Risk factors, Diabetes Mellitus, Type 2, Biomarkers - urine, type 2 - urine, Biomarkers
Prístupová URL adresa: https://europepmc.org/articles/pmc5911430?pdf=render
https://pubmed.ncbi.nlm.nih.gov/29398132
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911430/
https://www.kidney-international.org/article/S0085-2538(17)30892-X/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/29398132
https://www.sciencedirect.com/science/article/abs/pii/S008525381730892X
https://pubmed.ncbi.nlm.nih.gov/29398132/
https://europepmc.org/article/MED/29398132
https://www.sciencedirect.com/science/article/pii/S008525381730892X?via=ihub
https://doi.org/10.1016/j.kint.2017.11.024
https://ruj.uj.edu.pl/xmlui/handle/item/142862 -
10
Autori:
Zdroj: Néphrologie & Thérapeutique. 14:S31-S37
Predmety: Disease Management, Diabetic Nephropathies/diagnosis, Kidney, Prognosis, 3. Good health, 03 medical and health sciences, Diabetes Mellitus/therapy, 0302 clinical medicine, Albuminuria/etiology, Mass Screening/methods, Risk Factors, Diabetes Mellitus, Albuminuria, Humans, Mass Screening, Diabetic Nephropathies, Kidney/physiopathology, Glomerular Filtration Rate
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/29606261
https://europepmc.org/abstract/MED/29606261
https://www.ncbi.nlm.nih.gov/pubmed/29606261
https://pubmed.ncbi.nlm.nih.gov/29606261/
https://www.em-premium.com/article/1206543
https://www.sciencedirect.com/science/article/abs/pii/S1769725518300221 -
11
Autori: a ďalší
Zdroj: Front Endocrinol (Lausanne)
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in endocrinology, 12:670674Predmety: sex differences, Male, Biopsy, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, Endocrinology, Sex Factors, 0302 clinical medicine, risk factors, Humans, Diabetic Nephropathies, 10. No inequality, Retrospective Studies, Disease Progression [MeSH], Diabetic Nephropathies/diagnosis [MeSH], diabetic kidney disease, type 2 diabetes, Glomerular Filtration Rate [MeSH], Male [MeSH], Sex Factors [MeSH], end stage kidney disease, Diabetic Nephropathies/etiology [MeSH], Female [MeSH], Kidney Failure, Chronic/diagnosis [MeSH], Follow-Up Studies [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Biopsy [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Kidney Failure, Chronic/blood [MeSH], Kidney Failure, Chronic/etiology [MeSH], Prognosis [MeSH], Diabetic Nephropathies/blood [MeSH], 2. Zero hunger, Middle Aged, RC648-665, Prognosis, 3. Good health, Diabetes Mellitus, Type 2, Disease Progression, Kidney Failure, Chronic, Female, Biomarkers, Follow-Up Studies, Glomerular Filtration Rate
Prístupová URL adresa: https://www.frontiersin.org/articles/10.3389/fendo.2021.670674/pdf
https://pubmed.ncbi.nlm.nih.gov/34393995
https://doaj.org/article/33fa27f93df0497ab217279bcef67ec8
https://www.researchsquare.com/article/rs-61662/v1
https://www.frontiersin.org/articles/10.3389/fendo.2021.670674/full
https://pubmed.ncbi.nlm.nih.gov/34393995/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360678
https://www.researchsquare.com/article/rs-61662/v1.pdf?c=1631854016000
https://repository.publisso.de/resource/frl:6476253 -
12
Autori: Jenssen, Trond
Zdroj: Diabetesforum. 32(3):10
-
13
-
14
Autori:
Zdroj: Polski Merkuriusz Lekarski. 32(188):98-102
Predmety: Male, Diabetic nephropathies - diagnosis, C-reactive protein - metabolism, Albuminuria - complications, Albuminuria - diagnosis, Interleukin-6 - blood, Biomarkers - blood, Albuminuria - blood, Diabetes mellitus, type 2 - blood, Diabetic nephropathies - etiology, type 2 - complications, Glycated hemoglobin A, Humans, Female, Middle aged, Diabetic nephropathies - blood, Aged
-
15
Autori: a ďalší
Zdroj: Clinical Biomechanics, Vol. 24, No 9 (2009) pp. 716-721
Predmety: Male, ddc:174.957, Diabetic Nephropathies/diagnosis/*physiopathology, Acceleration, Posture, Monitoring, Ambulatory, Postural Balance, 03 medical and health sciences, 0302 clinical medicine, Humans, Diabetic Nephropathies, 618.92, 174.957, Diabetes Mellitus, Type 2/diagnosis/*physiopathology, ddc:617, Monitoring, Ambulatory/*methods, Middle Aged, 3. Good health, Diabetes Mellitus, Type 2, Female, ddc:618.92
Popis súboru: application/pdf
Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/19683372
https://www.ncbi.nlm.nih.gov/pubmed/19683372
https://www.sciencedirect.com/science/article/pii/S0268003309001624
https://pubmed.ncbi.nlm.nih.gov/19683372/
https://archive-ouverte.unige.ch/unige:20137
https://core.ac.uk/display/60826131
https://europepmc.org/abstract/MED/19683372
https://archive-ouverte.unige.ch/unige:20137 -
16
Prispievatelia: a ďalší
Predmety: Acetylglucosaminidase/urine, Aged, Albuminuria/diagnosis, Albuminuria/enzymology, Biomarkers/urine, Carotid Artery Diseases/diagnosis, Carotid Artery Diseases/enzymology, Carotid Artery Diseases/urine, Carotid Intima-Media Thickness, Chi-Square Distribution, Creatinine/urine, Cross-Sectional Studies, Diabetes Mellitus, Type 2/diagnosis, Type 2/enzymology, Type 2/urine, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/enzymology, Diabetic Nephropathies/urine, Early Diagnosis, Female, Humans, Kidney Tubules/enzymology, Linear Models, Logistic Models, Male, Middle Aged, Odds Ratio, Plaque, Atherosclerotic
Popis súboru: application/pdf
Relation: CARDIOVASCULAR DIABETOLOGY; J00460; 2002~; https://ir.ymlib.yonsei.ac.kr/handle/22282913/154177; T201700225; CARDIOVASCULAR DIABETOLOGY, Vol.16(1) : 16, 2017; 42141
-
17
Autori: a ďalší
Zdroj: Acta clinica Croatica. 46(3):259-264
Predmety: Diabetic nephropathies-therapy, Glomerulosclerosis focal-complications, Glomerulosclerosis focal-diagnosis, Glomerulosclerosis focal-therapy, Diabetic nephropathies-diagnosis, Diabetic nephropathies-immunology, Kidney, glomerules-pathology
Prístupová URL adresa: https://www.bib.irb.hr/378895
https://hrcak.srce.hr/clanak/28483 -
18
Autori: a ďalší
Zdroj: Endokrynologia Pediatryczna. 4(2(11)):9-16
Predmety: Diabetic nephropathies - diagnosis, Cystatins - diagnostic use, Adolescent, Cystatyny - krew, Dzieci, Nefropatie cukrzycowe - diagnostyka, Cukrzyca typu 1, Diabetes mellitus, type 1, Diabetes complications, Cystatins - blood, Powikłania cukrzycy, Child, Cystatyny - stosowanie diagnostyczne, Młodzież
-
19
Prispievatelia: a ďalší
Predmety: Acetylglucosaminidase/urine, Aged, Albuminuria/urine, Biomarkers/urine, Cross-Sectional Studies, Diabetes Mellitus, Type 2/metabolism, Type 2/urine, Diabetic Nephropathies/diagnosis, Diabetic Nephropathies/urine, Female, Glucose/metabolism, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, glycated albumin, N-acetyl-b-D-glucosaminidase, type 2 diabetes
Relation: MEDICINE; J02214; https://ir.ymlib.yonsei.ac.kr/handle/22282913/151679; T201602605; MEDICINE, Vol.95(27) : 4114, 2016; 45693
-
20
Full Text Finder
Nájsť tento článok vo Web of Science